Efficacy cardiotonic medicines on the bioenergetic processes and endothelial dysfunction under coupled of heart failure and systemic inflammatory syndroms in

The efficacy of cardiotonic drugs on the energy supply system and bioenergetic processes in failing myocardium under severe form heart failure (HF) coupled with systemic inflammatory response syndrom, has been studied in the randomized, controlled trial. It has been shown, that treatment with cardio...

Full description

Bibliographic Details
Main Authors: D. I. Ionov, M. M. Fedorova, P. A. Galenko-Yaroshevsky, T. D. Kezeli, M. A. Mirziashvili, M. D. Chipashvili, G. V. Sukoyan
Format: Article
Language:Russian
Published: Ministry of Healthcare of the Russian Federation. “Kuban State Medical University” 2016-02-01
Series:Кубанский научный медицинский вестник
Subjects:
Online Access:https://ksma.elpub.ru/jour/article/view/449
_version_ 1797295531458822144
author D. I. Ionov
M. M. Fedorova
P. A. Galenko-Yaroshevsky
T. D. Kezeli
M. A. Mirziashvili
M. D. Chipashvili
G. V. Sukoyan
author_facet D. I. Ionov
M. M. Fedorova
P. A. Galenko-Yaroshevsky
T. D. Kezeli
M. A. Mirziashvili
M. D. Chipashvili
G. V. Sukoyan
author_sort D. I. Ionov
collection DOAJ
description The efficacy of cardiotonic drugs on the energy supply system and bioenergetic processes in failing myocardium under severe form heart failure (HF) coupled with systemic inflammatory response syndrom, has been studied in the randomized, controlled trial. It has been shown, that treatment with cardioprotector (NAD- and cardiac glycoside-containing) drug Adenocin® unlike inhibitors of phosphodiesterase, amrinone and levosimendan, abolished the progression of bioenergetics failure and mitochondrial remodeling. Adenocin® occurs restoration of level of redox-potential NAD/NADH and cessates the release of cytochrome C from the mitochondries of cardiomyocyte. HF increased the content of ATP and creatinphosphate in left and right ventricle of myocardium, and restored the level of redox-potential NAD/NADH and cytochrome in mitochondria of cardiomyocytes, that leads in the basis of sharply decrease of ATP and creatinphosphate in myocardium, switch the lactate/pyruvate ratio to the increase of pyruvate (aerobic glycolysis). The linear positive correlation between redox-potential NAD/NADH in ventricular myocardium and blood and negative between level of cytochrome C in myocardium and blood has been shown.
first_indexed 2024-03-07T21:50:14Z
format Article
id doaj.art-35c59cfd2a5e49eab9096dd2d5d988ec
institution Directory Open Access Journal
issn 1608-6228
2541-9544
language Russian
last_indexed 2024-03-07T21:50:14Z
publishDate 2016-02-01
publisher Ministry of Healthcare of the Russian Federation. “Kuban State Medical University”
record_format Article
series Кубанский научный медицинский вестник
spelling doaj.art-35c59cfd2a5e49eab9096dd2d5d988ec2024-02-25T10:57:17ZrusMinistry of Healthcare of the Russian Federation. “Kuban State Medical University”Кубанский научный медицинский вестник1608-62282541-95442016-02-011525610.25207/1608-6228-2016-1-52-56449Efficacy cardiotonic medicines on the bioenergetic processes and endothelial dysfunction under coupled of heart failure and systemic inflammatory syndroms inD. I. Ionov0M. M. Fedorova1P. A. Galenko-Yaroshevsky2T. D. Kezeli3M. A. Mirziashvili4M. D. Chipashvili5G. V. Sukoyan6Kuban state medical universityRussian academy of postgraduate study Ministry of health and social developmentKuban state medical universityI. Javakhishvili Tbilisi state universityI. Javakhishvili Tbilisi state universityI. Javakhishvili Tbilisi state universityI. Javakhishvili Tbilisi state universityThe efficacy of cardiotonic drugs on the energy supply system and bioenergetic processes in failing myocardium under severe form heart failure (HF) coupled with systemic inflammatory response syndrom, has been studied in the randomized, controlled trial. It has been shown, that treatment with cardioprotector (NAD- and cardiac glycoside-containing) drug Adenocin® unlike inhibitors of phosphodiesterase, amrinone and levosimendan, abolished the progression of bioenergetics failure and mitochondrial remodeling. Adenocin® occurs restoration of level of redox-potential NAD/NADH and cessates the release of cytochrome C from the mitochondries of cardiomyocyte. HF increased the content of ATP and creatinphosphate in left and right ventricle of myocardium, and restored the level of redox-potential NAD/NADH and cytochrome in mitochondria of cardiomyocytes, that leads in the basis of sharply decrease of ATP and creatinphosphate in myocardium, switch the lactate/pyruvate ratio to the increase of pyruvate (aerobic glycolysis). The linear positive correlation between redox-potential NAD/NADH in ventricular myocardium and blood and negative between level of cytochrome C in myocardium and blood has been shown.https://ksma.elpub.ru/jour/article/view/449сердечная недостаточностькардиотонические средствабиоэнергетическая недостаточностьредокс-потенциалцитохром сheart failurecardiotonic drugbioenergetics failureredox-potentialcytochrome c
spellingShingle D. I. Ionov
M. M. Fedorova
P. A. Galenko-Yaroshevsky
T. D. Kezeli
M. A. Mirziashvili
M. D. Chipashvili
G. V. Sukoyan
Efficacy cardiotonic medicines on the bioenergetic processes and endothelial dysfunction under coupled of heart failure and systemic inflammatory syndroms in
Кубанский научный медицинский вестник
сердечная недостаточность
кардиотонические средства
биоэнергетическая недостаточность
редокс-потенциал
цитохром с
heart failure
cardiotonic drug
bioenergetics failure
redox-potential
cytochrome c
title Efficacy cardiotonic medicines on the bioenergetic processes and endothelial dysfunction under coupled of heart failure and systemic inflammatory syndroms in
title_full Efficacy cardiotonic medicines on the bioenergetic processes and endothelial dysfunction under coupled of heart failure and systemic inflammatory syndroms in
title_fullStr Efficacy cardiotonic medicines on the bioenergetic processes and endothelial dysfunction under coupled of heart failure and systemic inflammatory syndroms in
title_full_unstemmed Efficacy cardiotonic medicines on the bioenergetic processes and endothelial dysfunction under coupled of heart failure and systemic inflammatory syndroms in
title_short Efficacy cardiotonic medicines on the bioenergetic processes and endothelial dysfunction under coupled of heart failure and systemic inflammatory syndroms in
title_sort efficacy cardiotonic medicines on the bioenergetic processes and endothelial dysfunction under coupled of heart failure and systemic inflammatory syndroms in
topic сердечная недостаточность
кардиотонические средства
биоэнергетическая недостаточность
редокс-потенциал
цитохром с
heart failure
cardiotonic drug
bioenergetics failure
redox-potential
cytochrome c
url https://ksma.elpub.ru/jour/article/view/449
work_keys_str_mv AT diionov efficacycardiotonicmedicinesonthebioenergeticprocessesandendothelialdysfunctionundercoupledofheartfailureandsystemicinflammatorysyndromsin
AT mmfedorova efficacycardiotonicmedicinesonthebioenergeticprocessesandendothelialdysfunctionundercoupledofheartfailureandsystemicinflammatorysyndromsin
AT pagalenkoyaroshevsky efficacycardiotonicmedicinesonthebioenergeticprocessesandendothelialdysfunctionundercoupledofheartfailureandsystemicinflammatorysyndromsin
AT tdkezeli efficacycardiotonicmedicinesonthebioenergeticprocessesandendothelialdysfunctionundercoupledofheartfailureandsystemicinflammatorysyndromsin
AT mamirziashvili efficacycardiotonicmedicinesonthebioenergeticprocessesandendothelialdysfunctionundercoupledofheartfailureandsystemicinflammatorysyndromsin
AT mdchipashvili efficacycardiotonicmedicinesonthebioenergeticprocessesandendothelialdysfunctionundercoupledofheartfailureandsystemicinflammatorysyndromsin
AT gvsukoyan efficacycardiotonicmedicinesonthebioenergeticprocessesandendothelialdysfunctionundercoupledofheartfailureandsystemicinflammatorysyndromsin